levofloxacin / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   137 Trials   137 Trials   5343 News 


«12...79808182838485868788899091»
  • ||||||||||  levofloxacin / Generic mfg.
    Trial primary completion date:  Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations (clinicaltrials.gov) -  Jun 11, 2015   
    P3,  N=70, Recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2014 Trial primary completion date: Jan 2015 --> Jan 2020
  • ||||||||||  Trial primary completion date:  BISER: Bacteriology and Inflammation in Bronchiectasis (clinicaltrials.gov) -  Mar 10, 2015   
    P=N/A,  N=80, Recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Sep 2013 --> Dec 2017
  • ||||||||||  levofloxacin / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Pharmacokinetics of Levofloxacin in Intensive Care Unit (clinicaltrials.gov) -  Mar 7, 2015   
    P4,  N=52, Completed, 
    Trial primary completion date: Sep 2013 --> Dec 2017 Recruiting --> Completed | N=65 --> 52 | Trial primary completion date: Dec 2014 --> Sep 2014
  • ||||||||||  Zabolante (zabofloxacin) / Dong Wha
    Enrollment closed, Trial primary completion date:  Bacteriocide: Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin (clinicaltrials.gov) -  Feb 12, 2015   
    P1,  N=18, Active, not recruiting, 
    Recruiting --> Completed | N=65 --> 52 | Trial primary completion date: Dec 2014 --> Sep 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Apr 2015
  • ||||||||||  levofloxacin / Generic mfg.
    Enrollment open, Trial initiation date, Combination therapy:  Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) -  Feb 5, 2015   
    P2,  N=100, Recruiting, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Aug 2013 --> Jan 2015
  • ||||||||||  levofloxacin / Generic mfg.
    Trial primary completion date:  Pharmacokinetics of Levofloxacin in Intensive Care Unit (clinicaltrials.gov) -  Dec 7, 2014   
    P4,  N=65, Recruiting, 
    Initiation date: Feb 2014 --> Jun 2014 Trial primary completion date: Mar 2014 --> Dec 2014
  • ||||||||||  loperamide / Generic mfg., azithromycin / Generic mfg.
    Trial primary completion date:  Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea (clinicaltrials.gov) -  Oct 10, 2014   
    P=N/A,  N=510, Recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> Apr 2015
  • ||||||||||  levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., duloxetine / Generic mfg.
    Trial primary completion date:  Rechallenge, Potential Drug Induced Liver Injury (Kaiser) (clinicaltrials.gov) -  Jul 8, 2014   
    P=N/A,  N=1, Completed, 
    N=440 --> 600 Trial primary completion date: Feb 2014 --> Apr 2013
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD), Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Trial termination:  Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach (clinicaltrials.gov) -  Jul 8, 2014   
    P2,  N=17, Terminated, 
    Trial primary completion date: Feb 2014 --> Apr 2013 Active, not recruiting --> Terminated; Low rate of accrual
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD), Rituxan (rituximab) / Biogen, Zenyaku Holdings, Roche
    Enrollment change, Trial termination:  Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach (clinicaltrials.gov) -  Jul 8, 2014   
    P2,  N=17, Terminated, 
    Active, not recruiting --> Terminated; Low rate of accrual N=35 --> 17 | Active, not recruiting --> Terminated; Low rate of accrual
  • ||||||||||  levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., duloxetine / Generic mfg.
    Trial completion, Trial primary completion date:  Rechallenge, Potential Drug Induced Liver Injury (Kaiser) (clinicaltrials.gov) -  Jul 8, 2014   
    P=N/A,  N=1, Completed, 
    N=35 --> 17 | Active, not recruiting --> Terminated; Low rate of accrual Active, not recruiting --> Completed | Trial primary completion date: Feb 2014 --> Apr 2013